Identification of Novel Inhibitor of Enoyl-Acyl Carrier Protein Reductase (InhA) Enzyme in <i>Mycobacterium tuberculosis</i> from Plant-Derived Metabolites: An In Silico Study

<i>Mycobacterium tuberculosis</i> (<i>M.tb</i>.) enoyl-acyl carrier protein (ACP) reductase (InhA) is validated as a useful target for tuberculosis therapy and is considered an attractive enzyme to drug discovery. This study aimed to identify the novel inhibitor of the InhA enzyme, a potential targe...

Полное описание

Библиографические подробности

Главные авторы:	Kratika Singh, Niharika Pandey, Firoz Ahmad, Tarun Kumar Upadhyay, Mohammad Hayatul Islam, Nawaf Alshammari, Mohd Saeed, Lamya Ahmed Al-Keridis, Rolee Sharma
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2022-08-01
Серии:	Antibiotics
Предметы:	FAS-II gravacridonediol InhA molecular docking Rutaceae family tuberculosis
Online-ссылка:	https://www.mdpi.com/2079-6382/11/8/1038
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!